Okamura K, Jikuya T, Mitsui T, Hori M
Department of Cardiovascular Surgery, University of Tsukuba, Ibaraki, Japan.
Surg Today. 1994;24(6):566-9. doi: 10.1007/BF01884582.
Four patients who developed intractable supraventricular tachycardia (SVT) after open heart surgery were treated using a new therapeutic method of creating a pharmacological atrioventricular block by the continuous infusion of verapamil with ventricular pacing. Both the initial dose and the effective dose, being the verapamil dose necessary to maintain pharmacological atrioventricular block to prevent the recurrence of SVT, were surveyed with clinical results. The verapamil-induced hemodynamic changes observed 4 h and 8 h after treatment, as indicated by systolic arterial blood pressure, mean arteral blood pressure, heart rate, cardiac index, and urine volume, were compared with the values 1 h before treatment. After an initial low dose infusion of 0.07 +/- 0.02 mg/kg.h had been given, an effective and safe dose of 0.11 +/- 0.05 mg/kg.h was determined. Good hemodynamic and clinical results were achieved in all four patients who are now leading an active life. These results therefore encourage us to apply this therapeutic method for treating patients with intractable and recurrent SVT after open heart surgery.
4例心脏直视手术后发生顽固性室上性心动过速(SVT)的患者,采用持续静脉输注维拉帕米并进行心室起搏以建立药物性房室传导阻滞的新治疗方法进行治疗。研究了初始剂量和有效剂量(即维持药物性房室传导阻滞以预防SVT复发所需的维拉帕米剂量)及其临床效果。将治疗后4小时和8小时观察到的维拉帕米引起的血流动力学变化(以收缩压、平均动脉压、心率、心脏指数和尿量表示)与治疗前1小时的值进行比较。在初始以0.07±0.02mg/kg·h的低剂量输注后,确定了有效且安全的剂量为0.11±0.05mg/kg·h。所有4例患者均取得了良好的血流动力学和临床效果,目前生活均很活跃。因此,这些结果鼓励我们将这种治疗方法应用于治疗心脏直视手术后顽固性和复发性SVT患者。